Oriola-KD Oyj - Company Announcement

Oriola-KD's comparable figures for 2008 based on the new segment structure

Oriola-KD Corporation Stock Exchange Release 17 April 2009 at 10.00
a.m.

As announced earlier, Oriola-KD Corporation adopted new segment
structure for financial reporting as of 1 January 2009. The Interim
Report for 1January - 31March 2009 will be according to the new
structure.

Operating segments as of 1 January 2009 are Pharmaceutical Trade
Finland, Pharmaceutical Trade Sweden, Pharmaceutical Trade Russia,
Pharmaceutical Trade Baltics, Healthcare Trade and Dental Trade. The
new segment structure is in line with the Group's new organization
structure and internal reporting.

Oriola-KD's geographical segments as of 1 January 2009 are Finland,
Sweden, Russia, Baltic countries and other countries.

Below is presented Oriola-KD's comparable figures for 2008 according
to the new segment structure. The retail and wholesale businesses OOO
Vitim & Co and OOO Moron, acquired in Russia, have been consolidated
into Oriola-KD's accounts as of 1 April 2008. In attachment the
comparable figures are presented as they are reported in the Notes to
the Financial Statements and they are unaudited.

Segment information is presented according to IFRS standards. Items
below operating profit - financial items and taxes - are not
allocated to the segments.


Segment
information

             Pharma-  Pharma-  Pharma-  Pharma-
1 Jan 2008-  ceutical ceutical ceutical ceutical Health-
31 Dec 2008   Trade    Trade    Trade    Trade    care   Dental Group Group
EUR million  Finland   Sweden   Russia  Baltics   Trade  Trade  items total
Sale of
goods           528.7    531.1    316.3     35.4   147.6    0.0       1,559.2
Sale of
services          4.4      4.7      2.6      2.0     7.6                 21.3
Royalties         0.3      0.0      0.0      0.0     0.1                  0.4
Sales to
external
customers       533.4    535.9    318.9     37.4   155.2    0.0   0.0 1,580.8
Sales to
other
segments          0.7                        0.0     0.0         -0.7     0.0
Net
Sales           534.1    535.9    318.9     37.4   155.3    0.0  -0.7 1,580.8

Operating
profit           16.6      6.0      8.2      1.1     7.9    2.1  -5.6    36.4
Assets          164.2    228.7    246.2     11.2    55.5   28.5  56.3   790.6
Liabilities     148.3    171.1     94.4      4.1    21.8    0.0 165.4   605.1
Capital
expenditure       1.0      7.3    114.0      0.2     2.4    0.0   0.7   125.7
Depreciation
and
amortisation      2.8      2.0      1.9      0.3     2.9    0.0   0.0     9.8


Average
number
of
personnel         446      251    2,530      163     400           18   3,807





Geographical
segments

1 Jan 2008-
31 Dec 2008                                  Baltic     Other   Group
EUR million         Finland Sweden Russia countries countries   total
Sales to
external
customers             618.2  568.9  319.0      48.2      26.5 1,580.8
Assets                260.5  257.4  255.2      16.5       1.0   790.6
Capital expenditure     3.5    7.8  114.0       0.4       0.0   125.7




Net sales and
operating profit
by operating
segments


Net sales,          Q1/   Q2/   Q3/   Q4/ Jan-Dec
EUR million        2008  2008  2008  2008    2008
Pharmaceutical
Trade
Finland           127.6 132.7 129.1 144.0   533.4
Pharmaceutical
Trade
Sweden            139.8 141.0 129.2 125.9   535.9
Pharmaceutical
Trade
Russia              0.0  93.8  97.9 127.3   318.9
Pharmaceutical
Trade
Baltics            10.0   9.8   8.4   9.2    37.4
Healthcare
Trade              40.6  38.1  33.8  42.7   155.2
Dental
Trade               0.0   0.0   0.0   0.0     0.0
Group
total             318.0 415.4 398.4 449.1 1,580.8


Operating profit,   Q1/   Q2/   Q3/   Q4/ Jan-Dec
EUR million        2008  2008  2008  2008    2008
Pharmaceutical
Trade
Finland             3.9   3.2   4.8   4.7    16.6
Pharmaceutical
Trade
Sweden              1.7   1.6   1.4   1.3     6.0
Pharmaceutical
Trade
Russia              0.0  -1.0   0.3   8.9     8.2
Pharmaceutical
Trade
Baltics             0.3   0.3   0.2   0.3     1.1
Healthcare
Trade               2.9   1.5   1.8   1.7     7.9
Dental
Trade               0.6   0.4   0.3   0.8     2.1
Group
Administration
and others         -0.8  -1.8  -1.0  -1.9    -5.6
Group
total               8.5   4.2   7.9  15.8    36.4



Net sales
by market,          Q1/   Q2/   Q3/   Q4/ Jan-Dec
EUR million        2008  2008  2008  2008    2008
Finland           148.7 150.5 144.6 174.5   618.2
Sweden            155.7 157.8 144.4 111.1   568.9
Russia              0.0  93.8  97.9 127.3   319.0
Baltics
countries          12.7  12.5  10.9  12.1    48.2
Other
countries           0.8   0.8   0.8  24.1    26.5
Group
total             318.0 415.4 398.4 449.1 1,580.8



As net sales and operating profit of segments form Group's total net
sales and operating profit, reconciliations to corresponding amounts
are not presented.

Oriola-KD Corporation

Eero Hautaniemi
President and CEO


Kimmo Virtanen
Executive Vice President and CFO


Further information:

Eero Hautaniemi
President and CEO
tel. +358 (0)10 429 2109
e-mail: eero.hautaniemi@oriola-kd.com

Kimmo Virtanen
Executive Vice President and CFO
tel. +358 (0)10 429 2069
e-mail: kimmo.virtanen@oriola-kd.com

Pellervo Hämäläinen
Vice President, Communications and IR
tel. +358 (0)10 429 2497
e-mail: pellervo.hamalainen@oriola-kd.com

Distribution:
NASDAQ OMX Helsinki Ltd.
Key media

Released by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola-kd.com